DexCom Aktie
WKN: A0D9T1 / ISIN: US2521311074
07.01.2025 14:30:00
|
Dexcom to Present at 43rd Annual J.P. Morgan Healthcare Conference
DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the 43rd annual J.P. Morgan Healthcare Conference on January 13, 2025.
The live presentation is scheduled to begin at approximately 12:00 PM EST and will be concurrently webcast.
Links to the webcast will be available on the DexCom Investor Relations website at investors.dexcom.com and will be archived there for future reference.
About DexCom, Inc.
Dexcom empowers people to take control of health through innovative biosensing technology. Founded in 1999, Dexcom has pioneered and set the standard in glucose biosensing for more than 25 years. Its technology has transformed how people manage diabetes and track their glucose, helping them feel more in control and live more confidently.
Dexcom. Discover what you’re made of. For more information, visit www.dexcom.com.
Category: IR
View source version on businesswire.com: https://www.businesswire.com/news/home/20250107556169/en/

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu DexCom Inc.mehr Nachrichten
16:04 |
NASDAQ Composite Index-Titel DexCom-Aktie: So viel hätte eine Investition in DexCom von vor 5 Jahren gekostet (finanzen.at) | |
16:03 |
S&P 500-Handel aktuell: S&P 500 verbucht zum Start Verluste (finanzen.at) | |
16:03 |
NASDAQ-Handel NASDAQ 100 präsentiert sich zum Start leichter (finanzen.at) | |
16:03 |
Zurückhaltung in New York: NASDAQ Composite verliert zum Start (finanzen.at) | |
25.06.25 |
Zuversicht in New York: NASDAQ 100 steigt letztendlich (finanzen.at) | |
25.06.25 |
Anleger in New York halten sich zurück: NASDAQ 100 präsentiert sich am Mittwochnachmittag schwächer (finanzen.at) | |
24.06.25 |
Freundlicher Handel in New York: NASDAQ Composite beendet den Dienstagshandel im Plus (finanzen.at) | |
24.06.25 |
Börse New York: NASDAQ 100 letztendlich im Plus (finanzen.at) |
Analysen zu DexCom Inc.mehr Analysen
Aktien in diesem Artikel
DexCom Inc. | 71,33 | -3,26% |
|